bsri.myeloma.org
Assessment of Molecular Disease Heterogeneity in Patients with MM
Dr. Jens Hillengass (University of Heidelberg) is lead investigator for a Black Swan Research Initiative-supported study that assesses molecular disease heterogeneity in patients with multiple myel…